Several U.S. Supreme Court justices expressed skepticism this week over whether companies can patent genes, during a hearing that could reshape the future of the biotech industry. The court heard arguments over patents held by Myriad Genetics on two human genes, which, when mutated, give a woman a higher risk of developing breast or ovarian cancer. The patents give the Utah firm a monopoly on testing for those mutations. A lawyer for Myriad said that voiding the patents would deter other scientists and investors from trying to make advances with natural materials. But Justice Elena Kagan questioned whether, under Myriad’s argument, a patent could be awarded to the “first person who found a liver.” And Justice Samuel Alito—a conservative—noted that while a company could patent the process used to extract a cancer treatment from a leaf, it could not “patent the plant” itself.
Granting these absurd patents is not in the public interest, said Marcy Darnovsky in the Los Angeles Times. Myriad’s strict patent enforcement “means its test is the only available one to determine whether a woman has a genetic variant that increases her risk of cancer.” Women can’t get a second opinion, even when facing a decision about removing a healthy organ to lower their cancer risk.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Today's political cartoons - November 3, 2024Cartoons Sunday's cartoons - presidential pitching, wavering convictions, and more
-
Why Man United finally lost patience with ten HagTalking Point After another loss United sacked ten Hag in hopes of success in the Champion's League
-
Who are the markets backing in the US election?Talking Point Speculators are piling in on the Trump trade. A Harris victory would come as a surprise
-
The battle over religious exemptions for companiesfeature Conservative Supreme Court justices expressed support for Hobby Lobby's request to be exempted from the Affordable Care Act’s contraception mandate.
-
The plane that ‘vanished into thin air’
feature Officials from 25 countries focused their search on two vast northern and southern corridors that the Boeing 777 may have traveled.
-
Debt-ridden Detroit files for bankruptcy
feature Detroit entered uncharted waters after it became the largest American city to file for bankruptcy.
-
Romney under pressure over tax returns
feature Mitt Romney’s campaign was left on the defensive this week, after the Obama campaign launched a series of attacks on his business record.
-
An economy stuck in the doldrums
feature The outlook for the American economy darkened, as the latest jobs report showed it settling into a prolonged stagnation.
-
Is the jobs outlook improving?
feature Private-sector employment has climbed by an average of 250,000 jobs a month for three months running, but the economy is still struggling and unemployment remains high.
-
A divided high court gets down to business
feature The Supreme Court faces a slew of controversial cases that are likely to expose deep divisions between the court’s liberal and conservative wings.
-
The political battle over regulating Wall Street
feature Senate Democrats brought a financial reform package to the floor while Goldman Sachs executives endured 10 hours of questioning and Republicans balked at a number of provisions in the bill.